Even zero-cut advocates now concede to market sentiment
Even the staunchest opponents of easing U.S. interest rate policy are now conceding. Among them is Torsten Slok, chief economist of private equity fund Apollo Global Management and a fervent supporter of the zero-cut stance.
‘Timing a bull-market correction is pointless’
Few stocks remain untouched in a market correction. An attempt by the editorial team to find out what asset managers are buying during the dip immediately fails: “Timing a bull-market correction is pointless,” they say.
Asset owners do not need PE to fulfill fiduciary duty, investors say
While the old-school stocks and bonds portfolio is increasingly supplemented with private investments, specialists suggest this shift might be unnecessary.
How serious is the ‘Great Rotation’ to small cap stocks?
Is the surge in small-cap stocks the “Great Rotation” or just a speculative bubble? Investment Officer gauges the sentiment.
Investors turn to steepeners to capitalize on Fed cuts
European institutional investors wishing to capitalize on anticipated rate cuts by the Federal Reserve are turning to curve steepeners.
Lack of boldness in venture capital is Europe’s ‘costly weakness’
Economists at the International Monetary Fund (IMF) assert that Europeans invest insufficiently in venture capital.
Illiquidity, complexity restrain allocations to alternatives
Investment advisors in both the US and Europe have been expressing a desire to increase allocations to alternatives, but the average allocation has remained modest, according to gatekeeper surveys by Cerulli and PGIM.
Norway state pension fund now world’s biggest asset owner
Norway’s sovereign wealth fund, the Government Pension Fund Global, has dethroned its Japanese counterpart and is now the world’s largest asset owner.
Trump’s looming tariffs could trigger inflation shock
In the event of Donald Trump’s re-election as US President, a big shift in trade policy could happen.
For nervous investors, buffered ETFs offer a way out
More and more US ETF providers are launching buffered products that fully hedge downside risk. The costs, however, also eat into the returns.